Muscle-Building amino acids tested in liver disease patients
NCT ID NCT06121492
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking branched-chain amino acid (BCAA) supplements for 24 weeks can help people with liver cirrhosis who have low muscle mass (sarcopenia) regain muscle and improve strength. About 86 adults aged 18–85 will be randomly assigned to receive either BCAA or a placebo twice daily, along with diet and exercise advice. The main goal is to see if more people in the BCAA group recover from sarcopenia compared to the placebo group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS OF THE LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Bangkok, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Calf power may hold the key to healthy aging – a study investigates
- Squats may stave off muscle loss in older adults — a trial puts it to the test
- Meditation and exercise may combat muscle wasting in dialysis patients
- Plant protein from buriti fruit could help seniors stay strong and steady
- Muscle loss after Weight-Loss surgery: a closer look
- Ancient acupoint massage meets modern exercise: a new hope for aging muscles and sleep?